Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer
Interventions: DRUG: Atezolizumab 1200 mg in 20 ML Injection|DRUG: Inavolisib|DRUG: Ipatasertib|DRUG: Olaparib|DRUG: Sacituzumab govitecan|DRUG: Trastuzumab/pertuzumab
Sponsor: German Cancer Research Center